1. Semeraro C, Dorigotti L, Banfi S, Carpi C (1981) Pharmacological studies on cadralazine: a new antihypertensive vasodilator drug. J Cardiovasc Pharmacol 62: 455?467
2. van Brummelen P, Bühler FR, Kiowski W, Bolli P, Bertel O (1979) Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a beta-blocker and a diuretic. Int J Clin Pharmacol Ther Toxicol 17: 380?385
3. Pirrelli A, Nardecchia A, Pieri R, Motolese M (1984) Cadralazine in the treatment of mild and moderate hypertension. Curr Ther Res 36: 712?719
4. Salvadeo A, Villa G, Segagni S et al. (1985) Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension. Arzneim Forsch/Drug Res 35: 623?625
5. Catalano M, Parini J, Libretti A (1983) Cadralazine (ISF 2469): dose related antihypertensive activity after single oral administration to patients. Eur J Clin Pharmacol 24: 157?161